Spasticity in multiple sclerosis (MS) patients can be eased through a combination of botulinum toxin type A (BoNT-A) injections and rehabilitation. However, caregiver support is required to keep patients on this treatment, according to results of a retrospective analysis. The study, “Determinants of botulinum toxin discontinuation in multiple sclerosis: a retrospective study” was published in the…
Source: PSP
Read more: Botulinum Toxin Treats MS Spasticity, But Support and Rehab Seen as Crucial to Long-term Use